Today's Date
Siplizumab for Liver Transplant Tolerance
(
PEARL
)
ITN Protocol #:
ITN100ST
Branded Name:
PEARL
Treatment Protocol #:
Therapeutic Area:
Transplantation
Current Status:
Development
Summary:
Promoting Exhaustion and Regulation in in Liver Transplantation using Siplizumab
Clinical Operations Associate Director
Clinical Operations Manager
ITN Biologist
ITN Clinical Trial Physician
Study Personnel: